CION Ameerpet
Hearing that your brain tumour has come back is frightening — but a recurrence is not the end of the road. We will explain the options honestly, and walk this journey with you.
If a scan or new symptoms have shown that your brain tumour has returned, the fear can feel overwhelming. You deserve straight, gentle answers. The most important one is this: a recurrent brain tumour is not the end of the road. Real, effective treatment options remain — and the right one is chosen for your exact situation.
There is no single standard treatment for recurrence. According to NCCN and EANO guidance, the plan is individualised — shaped by your tumour type and grade, how much time has passed since your last treatment, where and how the tumour has returned, your fitness, and what you have already received. That is why every recurrence at CION is reviewed by a multidisciplinary tumour board before any recommendation is made.
This page explains how a recurrence is confirmed and what can be done about it. If you are still asking whether it could return at all, read can a brain tumour come back after removal? For the wider picture, see our brain cancer & tumour hub or explore brain tumour treatment in Hyderabad.
The first MRI after radiation and chemotherapy can be misleading. A phenomenon called pseudoprogression — treatment-related inflammation — can make a scan look worse than the tumour actually is, mimicking recurrence. Per EANO and NCCN guidance, distinguishing true recurrence from pseudoprogression often needs an experienced neuro-oncologist, repeat imaging over time, and sometimes advanced MRI techniques such as perfusion imaging. Getting this right prevents an unnecessary change of plan — which is exactly why an expert review, or a second opinion, is so valuable at recurrence.
Before treatment changes, the team must be sure a scan change is a true recurrence — not a treatment effect. Rushing this step can lead to the wrong plan.
Most recurrences are found on a routine surveillance MRI before symptoms appear. Comparing the new scan with previous ones shows whether an area is genuinely growing. This is why a planned follow-up schedule matters so much after your first treatment.
Treatment-related inflammation can look like regrowth on MRI. Experienced neuro-oncologists use repeat imaging over time and, where needed, advanced sequences such as perfusion MRI to tell true recurrence from pseudoprogression before acting.
Sometimes a recurrence first shows as new symptoms: a persistent or worsening headache, a new seizure or change in seizures, new one-sided weakness or speech difficulty, or new vision or memory change. Report these promptly rather than waiting for the next scan.
If a recent scan has worried you, don't sit with the uncertainty alone. Ask CION for an expert review before assuming the worst.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether you want a recurrence confirmed, retreatment options laid out clearly, or a free second opinion — CION's neuro-oncology tumour board is here. We make decisions for healing, not billing.
Once a recurrence is confirmed, the right treatment depends on the tumour type, where and how it has returned, the time since your last therapy, your fitness, and what you have had before. CION reviews every recurrence through a multidisciplinary tumour board before recommending a plan, drawing on NCCN and EANO guidance. Below are the main options — often used in combination rather than alone.
When a recurrence is in an accessible location and you are well enough, further maximal safe resection may be possible — removing as much of the returning tumour as can be done safely, while protecting speech and movement. Repeat surgery can relieve pressure, confirm the tumour biology again, and make later radiation or systemic therapy more effective. All neurosurgery is coordinated with accredited neurosurgical partners while CION plans and manages everything around the operation — imaging, molecular testing, and the recovery pathway. Whether repeat surgery is right for you is a tumour-board decision that weighs the benefit against the risk in your specific case.
Radiation can sometimes be given again. For a small, well-defined recurrence, CION's radiation oncology team can plan carefully targeted re-irradiation, or a recurrence may be suitable for stereotactic radiosurgery — highly focused beams converging on the tumour from many angles without any incision. Stereotactic radiosurgery is arranged as part of coordinated specialist care. Whether re-treatment is safe depends on the radiation dose the area received before, the time since your last course, and the location of the recurrence — all of which your team reviews before planning.
At recurrence, additional systemic therapy may be recommended — for example, further alkylating chemotherapy or anti-angiogenic treatment, chosen by the tumour type and what you had before. These medicines are delivered and monitored by CION's medical oncologists, with blood counts and side effects watched closely. The aim is to slow the tumour, relieve symptoms, and protect quality of life. The exact choice is individualised — there is no one-size-fits-all systemic plan for a recurrent brain tumour, which is why molecular re-testing matters (see below).
The biology of a tumour can be re-assessed at recurrence. Repeating molecular markers such as IDH status and MGMT methylation helps predict which treatments are most likely to work the second time, and can reveal changes since the original diagnosis. This information directly shapes the systemic therapy choice and helps set realistic expectations. CION arranges molecular testing as standard where a repeat tissue sample is available, and factors the results into every tumour-board discussion so your next line of treatment is guided by evidence, not guesswork.
For some recurrent tumours, a clinical trial offers access to newer treatment approaches that are not yet standard. Trials have careful eligibility rules and are not right for everyone, but they can be a valuable option — particularly for aggressive tumours where the standard menu is limited. Your neuro-oncology team can advise whether a trial is appropriate for your tumour type and situation, and help you understand what taking part would involve. This is one of the reasons a second opinion at recurrence can be worthwhile — to make sure every avenue has been considered.
Supportive care runs alongside every treatment plan, not after it. CION delivers steroid management to reduce brain swelling, seizure (antiepileptic) management, physiotherapy, speech therapy, and cognitive and emotional support to protect your day-to-day quality of life. For recurrent tumours, symptom control and wellbeing are central goals in their own right — not secondary to treatment. Our tumour board coordinates supportive care with any surgery, radiation or systemic therapy so the whole plan works together, and so you and your family feel supported at every step.
Options above are general and drawn from NCCN and EANO guidance. They describe what may be considered for groups of patients — not a prediction, recommendation, or guarantee for any one person. Your own plan is decided by your neuro-oncology team after reviewing your case.
Because glioblastoma and other high-grade gliomas recur in most patients despite full initial treatment, "my glioma came back" is one of the most common reasons families reach out. This is not a failure of your first treatment — it is the biology of an infiltrating tumour whose microscopic cells reach into normal-looking brain.
When a glioma or glioblastoma recurs, treatment is chosen from the options above and often combined: repeat surgery where the recurrence is accessible, focused re-irradiation or stereotactic radiosurgery for a small localised recurrence, further systemic therapy, molecular re-testing, and clinical trials where appropriate. There is no single standard for recurrence under NCCN and EANO guidance — the plan is individualised.
We will be honest with you throughout: for aggressive tumours, recurrence is usually treated as a long-term condition to be controlled rather than cured, and we will never promise a cure. What good care can genuinely do is extend meaningful time, ease symptoms, and keep you in control of the decisions. For a deeper look at this specific scenario, read our page on recurrent glioblastoma.
At recurrence the stakes are high and the options are less standardised than at first diagnosis — which is exactly when a careful second opinion earns its place. A fresh review can catch things that change the plan:
CION offers a free written second opinion reviewed by our multidisciplinary tumour board, with a 45-minute consultation and transparent costs. We walk this journey with you — explore brain tumour treatment in Hyderabad, or call us on 18002028726 to talk to a specialist today.
A recurrence is frightening, but it is not the end of the road. There is no single standard treatment for a recurrent brain tumour — per NCCN and EANO guidance, the plan is individualised from repeat surgery, re-irradiation or radiosurgery, further systemic therapy, molecular re-testing and clinical trials. For aggressive tumours, the honest aim is often to control the tumour and extend meaningful time rather than to cure it — and we will never promise a cure. What we can promise is a careful review, clear choices, and a team that walks this journey with you.
A free written second opinion from CION's neuro-oncology tumour board — so you know whether a scan change is true recurrence, and understand every option available to you.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Yes. A recurrence is not the end of the road, and real options remain. Depending on where and how the tumour returns, treatment may include repeat surgery (coordinated with accredited neurosurgical partners), re-irradiation or stereotactic radiosurgery, further systemic therapy, or a clinical trial. The right choice depends on your tumour type, how much time has passed since your last treatment, your fitness, and what you have had before. CION reviews every recurrence through a multidisciplinary tumour board before recommending a plan. If you want an honest, personalised review, speak to our team — we will explain what is realistically possible for your situation.
For a recurrent glioblastoma or other recurrent glioma, options are chosen case by case and often combined. They can include repeat maximal safe resection where the tumour is accessible, focused re-irradiation or stereotactic radiosurgery for a small localised recurrence, further systemic therapy such as anti-angiogenic or additional alkylating treatment, and clinical trials of newer approaches. Molecular re-testing of IDH status and MGMT methylation helps predict which treatments are most likely to work the second time. Per NCCN and EANO guidance, there is no single standard for recurrence — the plan is individualised by your neuro-oncology team.
Often, yes — but it depends on your situation. Repeat surgery may be possible when the recurrence is in an accessible location and you are well enough; all neurosurgery is coordinated with accredited neurosurgical partners while CION manages everything around it. Radiation can sometimes be given again as carefully planned re-irradiation, or as stereotactic radiosurgery for a small, well-defined recurrence, arranged as part of coordinated specialist care. Whether re-treatment is safe depends on how much radiation the area received before, the time since your last course, and the location of the recurrence. Your tumour board weighs these factors before recommending anything.
This is one of the most important questions after treatment. The first MRI after radiation and chemotherapy can show pseudoprogression — treatment-related inflammation that mimics regrowth on a scan without the tumour actually returning. According to EANO and NCCN guidance, distinguishing true recurrence from pseudoprogression or radiation change often needs an experienced neuro-oncologist, repeat imaging over time, and sometimes advanced MRI techniques such as perfusion imaging. Getting this right matters, because it prevents an unnecessary change of plan. If a recent scan has worried you, ask for an expert review before assuming the worst.
We will always be honest with you, and we never promise a cure. For some benign or low-grade tumours, a further treatment can control the recurrence for a long time, sometimes indefinitely. For aggressive tumours such as glioblastoma, recurrence is usually treated as a long-term condition to be controlled rather than cured. What good care can genuinely do is extend meaningful time, ease symptoms, and keep you in control of the decisions. Your neuro-oncologist can give you a realistic picture once your tumour type, grade, and molecular results are reviewed — not a number copied from a website.
A second opinion is especially valuable at recurrence — when the stakes are high and the options are less standardised. It is worth seeking one if a scan change is being called recurrence without pseudoprogression being ruled out, if re-treatment options such as repeat surgery or stereotactic radiosurgery have not been discussed, or if molecular re-testing (IDH, MGMT) has not been arranged to guide the next line of therapy. CION offers a free written second opinion reviewed by our multidisciplinary tumour board. Request one here — send your MRI, surgical pathology and any molecular results and we will review them carefully.
Supportive care is central to treating a recurrence, not an afterthought. CION delivers steroid management to reduce brain swelling, seizure (antiepileptic) management, physiotherapy, speech therapy, and cognitive and emotional support to protect your quality of life throughout. For recurrent brain metastases, systemic therapy for the primary cancer continues alongside brain-directed treatment. Our tumour board coordinates all of this so the different parts of your care work together. We walk this journey with you — call to talk it through with a specialist.
Disclaimer: This content is intended for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Treatment options described here are general and drawn from published guidance, including NCCN and EANO — they describe what may be considered for groups of patients, not predictions, recommendations, or guarantees for any one person. There is no single standard treatment for a recurrent brain tumour; every plan is individualised. Neurosurgery is coordinated with accredited neurosurgical partners. Always consult a qualified oncologist for guidance specific to your medical condition. This page is periodically reviewed and updated by CION's medical team in accordance with current clinical guidelines.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.